Company profile: Paladin Labs
1.1 - Company Overview
Company description
- Provider of innovative pharmaceutical products, headquartered in Montreal, Canada, specializing in researching, developing, acquiring, and in-licensing for the Canadian and world markets, supported by a focused national sales team and proven marketing expertise.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Paladin Labs
Valera Pharmaceuticals
HQ: United States
Website
- Description: Provider of specialty pharmaceutical services concentrating on development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Valera Pharmaceuticals company profile →
Sirtris Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical research and development focused on discovering and developing proprietary, orally available small molecule drugs to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sirtris Pharmaceuticals company profile →
InMed Pharmaceuticals
HQ: Canada
Website
- Description: Provider of cannabinoid-based pharmaceutical candidates and rare cannabinoid ingredients. Develops INM-755 (cannabinol topical for epidermolysis bullosa) and INM-088 (cannabinol-based for glaucoma). Through BayMedica, supplies bioidentical rare cannabinoids (CBC, d9-THCV, CBDV, CBTC) for B2B health and wellness. Offers IntegraSyn, combining biosynthesis and chemical synthesis to produce cannabinoids, aiming for high yield and cost efficiency.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InMed Pharmaceuticals company profile →
Centessa Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies and platforms, including SerpinPC, a biologic for hemophilia that inhibits activated protein C to reduce bleeding; an Orexin Receptor 2 agonist program for sleep-wake disorders; the LockBody technology platform designed to enhance immuno-oncology by selectively targeting the tumor microenvironment; and LB101, a conditionally tetravalent PD-L1 X CD47 bispecific monoclonal antibody for advanced solid tumors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Centessa Pharmaceuticals company profile →
BioXcel Therapeutics
HQ: United States
Website
- Description: Provider of AI-driven drug re-innovation and therapeutics, including IGALMI, an FDA-approved sublingual film for acute agitation in adults with schizophrenia or bipolar I/II; BXCL501, an investigational dissolving dexmedetomidine film for agitation related to Alzheimer’s dementia and bipolar or schizophrenia; BXCL701, an oral innate immune activator under investigation for aggressive prostate, pancreatic, and other solid and liquid tumors; plus an Expanded Access Program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioXcel Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Paladin Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Paladin Labs
2.2 - Growth funds investing in similar companies to Paladin Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Paladin Labs
4.2 - Public trading comparable groups for Paladin Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →